Literature DB >> 12875763

Glycosaminoglycan profiles of myxomatous mitral leaflets and chordae parallel the severity of mechanical alterations.

K Jane Grande-Allen1, Brian P Griffin, Norman B Ratliff, Delos M Cosgrove, Ivan Vesely.   

Abstract

OBJECTIVES: This biochemical study compared the extracellular matrix of normal mitral valves and myxomatous mitral valves with either unileaflet prolapse (ULP) or bileaflet prolapse (BLP).
BACKGROUND: Myxomatous mitral valves are weaker and more extensible than normal valves, and myxomatous chordae are more mechanically compromised than leaflets. Despite histological evidence that glycosaminoglycans (GAGs) accumulate in myxomatous valves, previous biochemical analyses have not adequately examined the different GAG classes.
METHODS: Leaflets and chordae from myxomatous valves (n = 41 ULP, 31 BLP) and normal valves (n = 27) were dried, dissolved, and assayed for deoxyribonucleic acid, collagen, and total GAGs. Specific GAG classes were analyzed with selective enzyme digestions and fluorophore-assisted carbohydrate electrophoresis.
RESULTS: Biochemical changes were more pronounced in chordae than in leaflets. Myxomatous leaflets and chordae had 3% to 9% more water content and 30% to 150% higher GAG concentrations than normal. Collagen concentration was slightly elevated in the myxomatous valves. Chordae from ULP had 62% more GAGs than those from BLP, primarily from elevated levels of hyaluronan and chondroitin-6-sulfate.
CONCLUSIONS: The GAG classes elevated in the myxomatous chordae are associated with matrix microstructure and elastic fiber deficiencies and may influence the hydration-related "floppy" nature of these tissues. These abnormalities may be related to the reported mechanical weakness of myxomatous chordae. The biochemical differences between ULP and BLP confirm previous mechanical and echocardiographic distinctions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875763     DOI: 10.1016/s0735-1097(03)00626-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  48 in total

1.  Consequences of mitral valve prolapse on chordal tension: ex vivo and in vivo studies in large animal models.

Authors:  Mathieu Granier; Morten O Jensen; Jesper L Honge; Alain Bel; Philippe Menasché; Sten L Nielsen; Alain Carpentier; Robert A Levine; Albert A Hagège
Journal:  J Thorac Cardiovasc Surg       Date:  2011-09-28       Impact factor: 5.209

Review 2.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

Review 3.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

4.  Differential proteoglycan and hyaluronan distribution in calcified aortic valves.

Authors:  Elizabeth H Stephens; Jerome G Saltarrelli; L Scott Baggett; Indrajit Nandi; Joyce J Kuo; Alan R Davis; Elizabeth A Olmsted-Davis; Michael J Reardon; Joel D Morrisett; Kathryn Jane Grande-Allen
Journal:  Cardiovasc Pathol       Date:  2010-12-24       Impact factor: 2.185

5.  In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation.

Authors:  Néha Datta; Quynh P Pham; Upma Sharma; Vassilios I Sikavitsas; John A Jansen; Antonios G Mikos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

6.  Cardiac transgenic matrix metalloproteinase-2 expression induces myxomatous valve degeneration: a potential model of mitral valve prolapse disease.

Authors:  Rajeev Mahimkar; Anita Nguyen; Michael Mann; Che-Chung Yeh; Bo-Qing Zhu; Joel S Karliner; David H Lovett
Journal:  Cardiovasc Pathol       Date:  2008-10-01       Impact factor: 2.185

Review 7.  Cellular mechanisms in mitral valve disease.

Authors:  Kareem Salhiyyah; Magdi H Yacoub; Adrian H Chester
Journal:  J Cardiovasc Transl Res       Date:  2011-09-03       Impact factor: 4.132

8.  Filamin-A as a Balance between Erk/Smad Activities During Cardiac Valve Development.

Authors:  Katelynn Toomer; Kimberly Sauls; Diana Fulmer; Lilong Guo; Kelsey Moore; Janiece Glover; Rebecca Stairley; Joyce Bischoff; Robert A Levine; Russell A Norris
Journal:  Anat Rec (Hoboken)       Date:  2018-10-05       Impact factor: 2.064

9.  Fibronectin-based isolation of valve interstitial cell subpopulations: relevance to valve disease.

Authors:  Elizabeth H Stephens; Thanh N Huynh; Jennifer D Cieluch; K Jane Grande-Allen
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

10.  The effects of mitral regurgitation alone are sufficient for leaflet remodeling.

Authors:  Elizabeth H Stephens; Tom C Nguyen; Akinobu Itoh; Neil B Ingels; D Craig Miller; K Jane Grande-Allen
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.